Northwestern Mutual Wealth Management
PLRX icon

Northwestern Mutual Wealth Management’s Pliant Therapeutics PLRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$126 – 4375
2026
Q1 		$126 Buy
+100
New +$126 ﹤0.01% 3982
2024
Q4 		– Sell
-30
Closed -$336 – 3820
2024
Q3 		$336 Buy
+30
New +$375 ﹤0.01% 3384

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Northwestern Mutual Wealth Management's PLRX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 100 shares — an estimated $126 sold.

Northwestern Mutual Wealth Management first reported a position in PLRX in Q3 2024 and held it in 2 quarters. The position peaked at $336 in Q3 2024. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 100 Pliant Therapeutics shares in Q2 2026, an estimated $126.
  • Northwestern Mutual Wealth Management first reported a position in Pliant Therapeutics in Q3 2024 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Pliant Therapeutics position peaked at $336 in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.